Fudim, Marat http://orcid.org/0000-0002-8671-7007
Blumer, Vanessa L.
Lopes, Renato D.
Rossignol, Patrick
Feldschuh, Michael
Miller, Wayne L.
Sobotka, Paul A.
Article History
Received: 12 July 2019
Accepted: 23 August 2019
First Online: 28 August 2019
Compliance with Ethical Standards
:
: No human or animal studies were carried out by the authors for this article.
: Marat Fudim is supported by an American Heart Association grant 17MCPRP33460225 and NIH T32 grant 5T32HL007101; he consults for Coridea, AxonTherapies, and Galvani. Renato D. Lopes research grants: Amgen, Bristol-Myers Squibb/Pfizer, GlaxoSmithKline, Medtronic PLC, Sanofi-Aventis; consulting/advisory board fees: Bristol-Myers Squibb/Pfizer, Bayer, Boehringer Ingelheim. Michael Feldschuh is an employee of Daxor. All other authors declare that they have no conflict of interest.
: Hypertension is one of the major health risk factors, and uncontrolled hypertension is highly prevalent. The physiology of hypertension is complex and knowledge of volume phenotypes might be relevant to clinical management.